Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Daiichi Sankyo’s Asubio Pharma Allocates $102 Million To Research Plant

This article was originally published in PharmAsia News

Executive Summary

Daiichi Sankyo subsidiary Asubio Pharma plans to spend $102 million to build a research facility near Kobe. Asubio planned the facility to be located near the world's fastest supercomputer expected to be available next year. The Daiichi Sankyo subsidiary already specializes in bio-based treatments for various ailments. Its facility is to be among one of 130 drug research and development facilities on Kobe's Port Island. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts